Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness and safety of abciximab (an anti-platelet therapy) versus placebo in patients undergoing high risk coronary angioplasty.


Clinical Trial Description

This is a randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy and safety of abciximab, an anti-platelet therapy, in patients undergoing high risk coronary angioplasty. The primary outcomes of the study include any of the following: the number of deaths from any cause, or myocardial infarctions and recurrent ischemic events requiring urgent intervention (e.g., repeat angioplasty, coronary artery bypass surgery, intracoronary stent placement, or intra-aortic balloon pump).

Patients receive an abciximab bolus, abciximab bolus plus infusion, or placebo. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00269893
Study type Interventional
Source Centocor, Inc.
Contact
Status Completed
Phase Phase 3
Start date November 1991
Completion date November 1992

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Completed NCT05466825 - Global Cardiovascular Risk Consortium
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT00692991 - Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures N/A
Recruiting NCT03715582 - Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes Phase 3
Recruiting NCT02760732 - Drug Eluting Balloon for Treatment of Unstable Angina N/A
Completed NCT01331707 - DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population Phase 4
Completed NCT00091507 - IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. Phase 3
Completed NCT02983123 - One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
Recruiting NCT06075602 - COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
Completed NCT02925923 - Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel Phase 2
Completed NCT04942977 - Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy N/A
Completed NCT00354328 - Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
Completed NCT00269906 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty Phase 3
Completed NCT03518645 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds N/A
Completed NCT00133003 - Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) Phase 4
Suspended NCT02776657 - Intracoronary Thrombus Detection by Magnetic Resonance Imaging N/A
Completed NCT01617863 - Hemodynamics During the Soccer Championship 2012 N/A
Completed NCT02581540 - Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
Completed NCT00905671 - Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study Phase 4